Results 111 to 120 of about 42,119 (250)

Antiarrhythmic treatment by amiodarone: present state and future

, 2019
The main purpose of this thesis is to make it easier for future medical doctors to understand the main function of amiodarone, its usage, its benefits, its functions as a clinical diagnostic tool, it's therapeutic monitoring and its side effects ...
Thorvaldsson, Thordur Gunnar
core  

Microfluidic production of amiodarone loaded nanoparticles and application in drug repositioning in ovarian cancer

Scientific Reports
Amiodarone repositioning in cancer treatment is promising, however toxicity limits seem to arise, constraining its exploitability. Notably, amiodarone has been investigated for the treatment of ovarian cancer, a tumour known for metastasizing within the ...
Asia Saorin, Gloria Saorin, Fahriye Duzagac, Pietro Parisse, Ni Cao, Giuseppe Corona, Enrico Cavarzerani, Flavio Rizzolio   +7 more
doaj   +1 more source

Beat‐to‐beat variability of ventricular repolarization reveals sex‐specific instability and proarrhythmic risk

The Journal of Physiology, EarlyView.
Abstract figure legend A mechanistic framework linking sex‐dependent dynamical instability to proarrhythmic risk. Sex‐specific human ventricular models show that upstream modulators, including biological sex, hormones, drugs and heart disease, promote steeper APD restitution in female than male and enhance dynamical instability.
Daisuke Sato, Lorenzo Santini, Raffaele Coppini, Eleonora Grandi   +3 more
wiley   +1 more source

Analgesic effects of amiodarone in mouse models of pain

Journal of Pain Research, 2019
Masakazu Kotoda,1 Hirofumi Ino,1 Yasutomo Kumakura,1 Tetsuya Iijima,1 Tadahiko Ishiyama,2 Takashi Matsukawa11Department of Anesthesiology, Faculty of Medicine, University of Yamanashi, Chuo, Yamanashi 409-3898, Japan; 2Surgical Center, University of ...
Kotoda M, Ino H, Kumakura Y, Iijima T, Ishiyama T, Matsukawa T   +5 more
doaj  

Risks of Appropriate Implantable Cardioverter Defibrillator Therapy and Hospitalization Are Increased Around Device‐Detected Atrial High‐Rate Episodes Longer Than 6 min

Journal of Arrhythmia, Volume 42, Issue 5, October 2026.
Device‐detected atrial high‐rate episodes (AHREs) lasting ≥ 6 min identify a transient period of increased clinical risk in ICD patients. During the 60‐day peri‐AHRE period, risks of appropriate ICD shock, any appropriate ICD therapy, and cardiac hospitalization were significantly increased.
Nanna Nørgaard, Christoffer Tobias Witt, Mads Brix Kronborg, Jens Cosedis Nielsen   +3 more
wiley   +1 more source

Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation

, 2023
Yihan Li,1 Tong Hu,1 Mingjie Lin,1,2 Qinhong Wang,1 Wenqiang Han,1 Jingquan Zhong1,2 1Department of Cardiology, Qilu Hospital of Shandong University, Jinan, Shandong Province, People’s Republic of China; 2Department of Cardiology, Qilu Hospital (Qingdao),
Li Y, Hu T, Wang Q, Han W, Zhong J, Lin M   +5 more
core  

Amiodarone Toxicity: A Case Report [PDF]

, 2019
Amiodarone is one of the commonly used drug in arrhythmias. It is first line of treatment for ventricular tachycardia particularly in treatment of supraventicular tachycardia like atrial fibrillation.
Ena Bhajni, Vijay Kumar, Hina Lal, Vijay K Sehgal, Jatinder Singh   +4 more
core   +1 more source

Novel Histopathologic Features of Diffuse Blue‐Gray Hyperpigmentation Associated With Kratom Use: A Case Report and Literature Review

Journal of Cutaneous Pathology, Volume 53, Issue 10, Page 887-892, October 2026.
ABSTRACT Background Drug‐induced hyperpigmentation accounts for 10%–20% of acquired pigmentary disorders and can be misdiagnosed for other causes such as melasma, post inflammatory changes, or heavy metal deposition. Kratom (Mitragyna speciosa), a Southeast Asian plant with an opioid‐like profile, has been increasingly used in the United States for ...
Rita Kamoua, Kristen Paradine, Craig A. Rohan, Mary McDaniel, Diane Perkins   +4 more
wiley   +1 more source

Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation

Drug Design, Development and Therapy, 2017
Rasmus Rivinius,1 Matthias Helmschrott,1 Arjang Ruhparwar,2 Fabrice F Darche,1 Dierk Thomas,1 Tom Bruckner,3 Hugo A Katus,1 Andreas O Doesch1 1Department of Cardiology, Angiology and Pneumology, 2Department of Cardiac Surgery, Heidelberg University ...
Rivinius R, Helmschrott M, Ruhparwar A, Darche FF, Thomas D, Bruckner T, Katus HA, Doesch AO   +7 more
doaj  

Impact of early intravenous amiodarone administration on neurological outcome in refractory ventricular fibrillation: retrospective analysis of prospectively collected prehospital data

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 2019
Background The 2015 AHA guidelines recommend that amiodarone should be used for patients with refractory ventricular fibrillation (RVF). However, the optimal time interval between the incoming call and amiodarone administration (call-to-amiodarone ...
Dong Keon Lee, Yu Jin Kim, Giwoon Kim, Choung Ah. Lee, Hyung Jun Moon, Jaehoon Oh, Hae Chul Yang, Han Joo Choi, Young Taeck Oh, Seung Min Park   +9 more
doaj   +1 more source